Daniel Eisenkraft Klein is a PhD Candidate at the Dalla Lana School of Public Health and a Fellow at the Canadian Centre for Health Economics, funded by a Social Sciences and Humanities Research Council Doctoral Fellowship. His primary research agenda explores how the tobacco and pharmaceutical industries influence policy stakeholders to provide favourable regulatory environments. Daniel is also a Sessional Instructor at Simon Fraser University on the commercial determinants of health, and serves as an Expert Consultant for Johns Hopkins University’s Opioid Industry Documents Archive.